Stay updated on Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the study record presentation. No substantive study information appears to be changed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, signaling a new build of the page. This update represents a software/version change rather than a modification to the study details or results.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page.SummaryDifference0.1%

- Check69 days agoChange DetectedThe collaborator list now includes Tri-Service General Hospital (TSGH) and the page revision is updated to v3.6.3, replacing the previous Tri-Service General Hospital entry and revision v3.6.2.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update to the page's revision history. No study content or data appear to be modified.SummaryDifference0.1%

- Check91 days agoChange DetectedEnrollment status now shows that no participants are being recruited. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Revision: v3.6.0; the Intervention / Treatment heading was reformatted to Intervention/Treatment.SummaryDifference0.4%

Stay in the know with updates to Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Neoadjuvant Therapy Clinical Trial page.